Hinge Bio
PrivateLast Round
Series A
Jan 15, 2025
Est. Valuation
$46M
Total Funding Raised
$30M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hinge Bio is a biotechnology company that develops multispecific antibody therapeutics for autoimmune diseases, inflammatory diseases, and cancer using its proprietary GEM-DIMER™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hinge Bio Comparables
Compare Hinge Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Candid Therapeutics | 79% | |
| Dren Bio | 78% | |
| Cullinan Oncology | 77% | |
Hinge Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 15, 2025 |
Key People
Founding team and executive leadership
Hinge Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thornapple River Capital | Series A |
| Ridgeback Capital | Series A |
| InVivium Capital | Series A |
| Point72 | Series A |
| Lightswitch Capital | Series A |
| Point72 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 70% MoM.
- Oct 13, 2025
Regulatory milestone achieved for Lupus therapy, enabling clinical trials.
Hinge Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hinge Bio's valuation, stock price, and market status.